Variant · Fusion
NUTM2B Fusion
CI-VAR-00001479Explore in graph →CIViC 5207
Curated evidence
Evidence by cancer (1 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
civicProvenance
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 39985394
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| CIC-Rearranged Sarcoma1 | ||||||||
| CIC::DUX4 Fusion OR CIC::LEUTX Fusion OR CIC::NUTM1 Fusion OR CIC::NUTM2B Fusion OR ATXN1::NUTM1 Fusion OR ATXN1::NUTM2B Fusion OR DOCK1::DUX4 Fusion | (diagnostic) | Diagnostic | B | Supports Positive | 4 | submitted | EID12515The cohort included 44 CIC-rearranged sarcomas (CIC-RS), comprising 18 central nervous system (CNS) and 26 extra-CNS tumors. RNA sequencing (n=27) identified CIC::DUX4 (n=15), CIC::NUTM1 (n=4), CIC::L… (full text at CIViC) PMID 39985394 · Koo et al., 2025 · Open in CIViC | civic |
ClinVar
Clinical significance (0)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
Data not yet available
No ClinVar interpretation attached to this variant.